Zaidi E, Bachur R, Harper M
Department of Internal Medicine, University of Pittsburgh Medical Center, Mckeesport, PA, USA.
Pediatr Infect Dis J. 1999 Dec;18(12):1073-7. doi: 10.1097/00006454-199912000-00009.
Non-typhi Salmonella (NTS) infections are a frequent cause of self-limited diarrheal illness in healthy children. Bacteremia is a known complication of NTS infection, but the management of children with bacteremia has been based on limited data.
To study the outcomes of pediatric patients with NTS bacteremia.
Retrospective review of patients with NTS bacteremia covering a 16-year period at an urban pediatric hospital. Clinical data from the initial visits and any follow-up visits or hospitalizations were abstracted from the medical record.
We studied 144 patients. Median age was 10.5 months. Fifty-four patients were hospitalized at the initial visit including all the patients with immunodeficiency (n = 12). Of the 90 patients initially managed as outpatients, 79 were subsequently admitted; only 1 of these patients developed a focal complication. Persistent bacteremia was found in 51 (41%) patients. Among nonimmunocompromised patients, persistent bacteremia was noted in 34% [95% confidence interval (CI), 20 to 52%] of those initially treated with oral antibiotics, 52% (CI 30 to 74%) of those initially treated with a parenteral dose of antibiotics and in 31% (CI 22 to 43%) of those who were not initially given antibiotics. No laboratory or clinical factors predicted persistent bacteremia. Twelve patients developed focal infections: 3 of 119 previously healthy children (2.5%, CI 0.5 to 7%); and 9 of 25 children with underlying medical conditions (36%, CI 19 to 57%). Focal infections included meningitis (3), osteomyelitis (4), septic arthritis (2), pneumonia (2) and cholangitis (1).
NTS bacteremia occurs in otherwise healthy children, although the risk of focal infections is small. Patients with NTS bacteremia frequently have persistent bacteremia at follow-up regardless of initial antibiotic treatment.
非伤寒沙门菌(NTS)感染是健康儿童自限性腹泻病的常见病因。菌血症是NTS感染的已知并发症,但菌血症患儿的治疗依据的数据有限。
研究NTS菌血症儿科患者的转归。
对一家城市儿科医院16年间NTS菌血症患者进行回顾性研究。从病历中提取初次就诊及任何后续就诊或住院的临床资料。
我们研究了144例患者。中位年龄为10.5个月。54例患者初次就诊时住院,包括所有免疫缺陷患者(n = 12)。在最初作为门诊治疗的90例患者中,79例随后入院;这些患者中只有1例出现局灶性并发症。51例(41%)患者存在持续性菌血症。在非免疫受损患者中,最初接受口服抗生素治疗的患者中34%[95%置信区间(CI),20%至52%]出现持续性菌血症,最初接受静脉抗生素治疗的患者中52%(CI 30%至74%)出现持续性菌血症,最初未给予抗生素治疗的患者中31%(CI 22%至43%)出现持续性菌血症。没有实验室或临床因素可预测持续性菌血症。12例患者发生局灶性感染:119例既往健康儿童中有3例(2.5%,CI 0.5%至7%);25例有基础疾病的儿童中有9例(36%,CI 19%至57%)。局灶性感染包括脑膜炎(3例)、骨髓炎(4例)、化脓性关节炎(2例)、肺炎(2例)和胆管炎(1例)。
NTS菌血症发生于其他方面健康的儿童,尽管发生局灶性感染的风险较小。NTS菌血症患者随访时经常存在持续性菌血症,无论初始抗生素治疗情况如何。